Nomogram predicting 5-year progression-free survival after secondary surgical cytoreduction for platinum-sensitive recurrent ovarian cancer

Kim, Christine

247 - Poster Session A
Nomogram predicting 5-year progression-free survival after secondary surgical cytoreduction for platinum-sensitive recurrent ovarian cancer

Saturday, March 22, 2014: 9:25 PM

West Exhibit Hall (Tampa Convention Center)

C. H. Kim¹, L. Kou², C. Yu², J. S. Taylor³, O. Zivanovic⁴, R. R. Barakat⁵, V. Makker⁵, M. W. Kattan² and D. S. Chi⁵
¹Thomas Jefferson University Hospital, Philadelphia, PA, ²The Cleveland Clinic, Cleveland, OH, ³New York-Presbyterian Hospital - Weill Cornell Medical College, New York, NY, ⁴Memorial Sloan Kettering Cancer Center, New York, NY, ⁵Memorial Sloan-Kettering Cancer Center, New York, NY

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

247 - Poster Session A
Nomogram predicting 5-year progression-free survival after secondary surgical cytoreduction for platinum-sensitive recurrent ovarian cancer

247 - Poster Session A Nomogram predicting 5-year progression-free survival after secondary surgical cytoreduction for platinum-sensitive recurrent ovarian cancer

247 - Poster Session A
Nomogram predicting 5-year progression-free survival after secondary surgical cytoreduction for platinum-sensitive recurrent ovarian cancer